Effect of a novel phosphodiesterase type 5 inhibitor,CPD1,on unilateral renal interstitial fibrosis caused by ureteric obstruction in mice
- Author:
Ao-Lu LIU
1
;
Wen-Bin FENG
1
;
Bin LI
1
;
Xin-Hui CHEN
1
;
Si-Rong LI
1
;
Zi-Jian ZHAO
1
;
Yun-Ping MU
1
;
Fang-Hong LI
1
;
Qian REN
2
Author Information
- Publication Type:Journal Article
- Keywords: collagen deposition; CPD1; kidney injury; phosphodiesterase type 5 inhibitor; renal interstitial fibrosis; unilateral ureteric obstruction
- From: Chinese Pharmacological Bulletin 2023;39(1):147-152
- CountryChina
- Language:Chinese
- Abstract: Aim To investigate the effects of CPD1,a novel phosphodiesterase 5 inhibitor,on renal pathological phenotype and fibrotic protein expression in renal fibrosis model mice. Methods Male C57BL/6 J mice were divided into three groups randomly(sham group,UUO group and UUO+CPD1 group). Unilateral ureteric obstruction model was constructed by surgery,and CPD1(5 mg·kg-1·d-1)was administered by intragastric administration two hours after the modeling for seven days. HE and Sirius Red staining were used to observe the distribution of tissue structural lesions and fibrosis. Immunohistochemical staining and Western blot were used to detect the expression of fibronectin(FN),α-SMA,collagen-I and kidney injury molecule-1(Kim-1). Results Compared with sham operation group,the renal tubules of mice were dilated and accompanied by a large amount of inflammatory infiltration. Moreover,the expressions of FN,α-SMA,collagen-I and Kim-1 proteins increased significantly(P<0.05)in UUO group. CPD1 treatment improved the kidney structure and decreased the expression of collagen fibers. Furthermore,CPD1 inhibited the expression of FN,α-SMA,collagen-I and Kim-1 markedly(P<0.05). Conclusions Phosphodiesterase 5 inhibitor CPD1 alleviates the progression of renal fibrosis induced by unilateral ureteral obstruction through down-regulating ECM deposition in the extracellular matrix and expression of Kim-1. The specific mechanism remains to be further studied.
